login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CRINETICS PHARMACEUTICALS IN (CRNX) Stock News
NASDAQ:CRNX -
US22663K1079
-
Common Stock
30.93
USD
+0.84 (+2.79%)
Last: 8/26/2025, 8:23:03 PM
31.53
USD
+0.6 (+1.94%)
After Hours:
8/26/2025, 8:23:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CRNX Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: Chartmill
- Mentions:
VKTX
SNGX
BTAI
AREC
...
Tuesday's pre-market session: top gainers and losers
6 days ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
6 days ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
8 days ago - By: Benzinga
- Mentions:
IBIO
SNGX
SNTI
VKTX
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
15 days ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 days ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 days ago - By: The Motley Fool
Crinetics (CRNX) Q2 Revenue Jumps 150%
19 days ago - By: Zacks Investment Research
- Mentions:
CASI
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates
19 days ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
20 days ago - By: Benzinga
- Mentions:
GSAT
PGY
ADV
REAL
...
Earnings Scheduled For August 7, 2025
a month ago - By: Yahoo Finance
Crinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 Data
a month ago - By: Yahoo Finance
- Mentions:
GS
Crinetics Pharmaceuticals (CRNX) Gets Initiated With a Hold Rating at Goldman Sachs
a month ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
a month ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Yahoo Finance
Should You Hold Crinetics Pharmaceuticals (CRNX)?
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
2 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
3 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
4 months ago - By: Zacks Investment Research
- Mentions:
OPTN
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
5 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
5 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
5 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Please enable JavaScript to continue using this application.